Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Amazon
AMZN
|
$307M |
| 2 |
Walmart
WMT
|
$213M |
| 3 |
Verizon
VZ
|
$201M |
| 4 |
Zurn Elkay Water Solutions
ZWS
|
$175M |
| 5 |
Home Depot
HD
|
$171M |
Top Sells
| 1 |
Charter Communications
CHTR
|
$277M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$241M |
| 3 |
SYKE
SYKES Enterprises Inc
SYKE
|
$165M |
| 4 |
Huntington Bancshares
HBAN
|
$158M |
| 5 |
Microsoft
MSFT
|
$144M |
Sector Composition
| 1 | Financials | 17.76% |
| 2 | Technology | 16.31% |
| 3 | Industrials | 12.65% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Healthcare | 10.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Korro Bio
KRRO
$312M
| $165K | ﹤0.01% |
467
-272
| -37% | -$96.1K |
|
3377
Comstock Holding Companies
CHCI
$187M
| $164K | ﹤0.01% |
+34,235
| New | +$164K |
|
|
GOGL
3378
DELISTED
Golden Ocean Group
GOGL
| $156K | ﹤0.01% |
14,527
| – | – |
|
|
OPGN
3379
DELISTED
OpGen, Inc
OPGN
| $154K | ﹤0.01% |
+267
| New | +$154K |
|
3380
Taitron Components
TAIT
$12.8M
| $153K | ﹤0.01% |
39,708
-13,063
| -25% | -$50.3K |
|
3381
Solid Biosciences
SLDB
$428M
| $152K | ﹤0.01% |
4,231
| – | – |
|
3382
One Stop Systems
OSS
$126M
| $151K | ﹤0.01% |
29,931
-5,620
| -16% | -$28.4K |
|
|
APTO
3383
DELISTED
Aptose Biosciences, Inc.
APTO
| $149K | ﹤0.01% |
+152
| New | +$149K |
|
3384
NextDecade
NEXT
$2.8B
| $148K | ﹤0.01% |
53,178
-3,486
| -6% | -$9.7K |
|
3385
Savara
SVRA
$643M
| $148K | ﹤0.01% |
107,285
| – | – |
|
|
MYND
3386
Mynd.ai
MYND
$25.9M
| $146K | ﹤0.01% |
5,117
+103
| +2% | +$2.94K |
|
3387
SELLAS Life Sciences
SLS
$201M
| $146K | ﹤0.01% |
15,924
-4,396
| -22% | -$40.3K |
|
|
AVEO
3388
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $146K | ﹤0.01% |
23,683
-4,662
| -16% | -$28.7K |
|
3389
Passage Bio
PASG
$22.8M
| $145K | ﹤0.01% |
+730
| New | +$145K |
|
3390
Globalstar
GSAT
$3.96B
| $142K | ﹤0.01% |
5,676
+829
| +17% | +$20.7K |
|
|
HEXO
3391
DELISTED
HEXO Corp. Common Shares
HEXO
| $142K | ﹤0.01% |
+5,507
| New | +$142K |
|
3392
ClearOne
CLRO
$8.52M
| $141K | ﹤0.01% |
3,987
| – | – |
|
3393
Karyopharm Therapeutics
KPTI
$57.2M
| $137K | ﹤0.01% |
1,571
-35
| -2% | -$3.05K |
|
|
CEMI
3394
DELISTED
Chembio diagnostics, Inc.
CEMI
| $137K | ﹤0.01% |
54,662
| – | – |
|
|
PTNR
3395
DELISTED
Partner Communications
PTNR
| $136K | ﹤0.01% |
29,361
| – | – |
|
|
ADIL
3396
Adial Pharmaceuticals
ADIL
$7.61M
| $135K | ﹤0.01% |
1,256
| – | – |
|
3397
QuickLogic
QUIK
$84.4M
| $132K | ﹤0.01% |
24,690
-3,891
| -14% | -$20.8K |
|
3398
Myomo
MYO
$37.7M
| $128K | ﹤0.01% |
10,801
-857
| -7% | -$10.2K |
|
3399
Xenetic Biosciences
XBIO
$4.73M
| $128K | ﹤0.01% |
+6,235
| New | +$128K |
|
3400
Beyond Air
XAIR
$11.5M
| $127K | ﹤0.01% |
+569
| New | +$127K |
|